Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY — Palo Alto, California

Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY?

Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY conducted?

Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma.

Is Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY accredited by Crixeo Health?

Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University Medical Center - Cancer Clinical Trials Office - ONCOLOGY?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.